310 related articles for article (PubMed ID: 37006260)
1. Roles of macrophages on ulcerative colitis and colitis-associated colorectal cancer.
Zhang M; Li X; Zhang Q; Yang J; Liu G
Front Immunol; 2023; 14():1103617. PubMed ID: 37006260
[TBL] [Abstract][Full Text] [Related]
2. Advancements of Macrophages Involvement in Pathological Progression of Colitis-Associated Colorectal Cancer and Associated Pharmacological Interventions.
Ke JY; Song JB; Li L; He ZF; Huang ZJ; Liu ZL; Chen GR; Wang HY; Wen SR; Zhou HL; Ma HL; Du Q; Wu YQ; Li YW; Chen XL
Chin J Integr Med; 2024 Jun; 30(6):565-576. PubMed ID: 38565799
[TBL] [Abstract][Full Text] [Related]
3. Suppression of microRNA-222-3p ameliorates ulcerative colitis and colitis-associated colorectal cancer to protect against oxidative stress
Wang XJ; Zhang D; Yang YT; Li XY; Li HN; Zhang XP; Long JY; Lu YQ; Liu L; Yang G; Liu J; Hong J; Wu HG; Ma XP
Front Immunol; 2023; 14():1089809. PubMed ID: 36776858
[TBL] [Abstract][Full Text] [Related]
4. The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer.
Wang Q; Li XL; Mei Y; Ye JC; Fan W; Cheng GH; Zeng MS; Feng GK
J Mol Med (Berl); 2020 Oct; 98(10):1457-1466. PubMed ID: 32840638
[TBL] [Abstract][Full Text] [Related]
5. Thalidomide Attenuates Colitis and Is Associated with the Suppression of M1 Macrophage Polarization by Targeting the Transcription Factor IRF5.
Lu J; Liu D; Tan Y; Li R; Wang X; Deng F
Dig Dis Sci; 2021 Nov; 66(11):3803-3812. PubMed ID: 34085173
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-Loaded Lipid Calcium Phosphate Nanoparticles Treat Experimental Colitis by Regulating Macrophage Polarization in Inflammatory Sites.
Dong K; Zhang Y; Ji HR; Guan ZL; Wang DY; Guo ZY; Deng SJ; He BY; Xing JF; You CY
Int J Nanomedicine; 2024; 19():993-1016. PubMed ID: 38299194
[TBL] [Abstract][Full Text] [Related]
8. Pyroptosis-Related Signature Predicts the Progression of Ulcerative Colitis and Colitis-Associated Colorectal Cancer as well as the Anti-TNF Therapeutic Response.
Ning Y; Lin K; Fang J; Chen X; Hu X; Liu L; Zhao Q; Wang H; Wang F
J Immunol Res; 2023; 2023():7040113. PubMed ID: 36741232
[TBL] [Abstract][Full Text] [Related]
9. Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization.
Wu MM; Wang QM; Huang BY; Mai CT; Wang CL; Wang TT; Zhang XJ
Pharmacol Res; 2021 Oct; 172():105796. PubMed ID: 34343656
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tumor-associated macrophages in colitis-associated colorectal cancer.
Dong Y; Yang Q; Niu R; Zhang Z; Huang Y; Bi Y; Liu G
J Cell Physiol; 2022 Dec; 237(12):4443-4459. PubMed ID: 36302153
[TBL] [Abstract][Full Text] [Related]
11. Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer.
Xun J; Zhou S; Lv Z; Wang B; Luo H; Zhang L; Yang L; Zhang A; Wu X; Wang Z; Wang X; Yu X; Zhang Q
Int Immunopharmacol; 2023 Apr; 117():109839. PubMed ID: 36809720
[TBL] [Abstract][Full Text] [Related]
12. Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer.
Ling Q; Fang J; Zhai C; Huang W; Chen Y; Zhou T; Liu Y; Fang X
Eur J Pharmacol; 2023 Jun; 949():175724. PubMed ID: 37059377
[TBL] [Abstract][Full Text] [Related]
13. Tiliroside Ameliorates Ulcerative Colitis by Restoring the M1/M2 Macrophage Balance
Zhuang H; Lv Q; Zhong C; Cui Y; He L; Zhang C; Yu J
Front Immunol; 2021; 12():649463. PubMed ID: 33868286
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Nrf2 in the treatment of ulcerative colitis via regulating macrophage polarization.
Zhang Y; Liu Y; Yang S; Yan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 48(11):1746-1752. PubMed ID: 38432866
[TBL] [Abstract][Full Text] [Related]
15. A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization.
Yang Z; Lin S; Feng W; Liu Y; Song Z; Pan G; Zhang Y; Dai X; Ding X; Chen L; Wang Y
Front Pharmacol; 2022; 13():999179. PubMed ID: 36147340
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model.
Wang W; Li X; Zheng D; Zhang D; Huang S; Zhang X; Ai F; Wang X; Ma J; Xiong W; Zhou Y; Li G; Shen S
Inflamm Res; 2013 Jul; 62(7):669-80. PubMed ID: 23625042
[TBL] [Abstract][Full Text] [Related]
17. Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation.
Lv Q; Xing Y; Liu Y; Chen Q; Xu J; Hu L; Zhang Y
Pharmacol Res; 2021 Jul; 169():105613. PubMed ID: 33915297
[TBL] [Abstract][Full Text] [Related]
18. Berberine promotes M2 macrophage polarisation through the IL-4-STAT6 signalling pathway in ulcerative colitis treatment.
Xiong K; Deng J; Yue T; Hu W; Zeng X; Yang T; Xiao T
Heliyon; 2023 Mar; 9(3):e14176. PubMed ID: 36923882
[TBL] [Abstract][Full Text] [Related]
19. Identifying neutrophil-associated subtypes in ulcerative colitis and confirming neutrophils promote colitis-associated colorectal cancer.
Zhang C; Zhang J; Zhang Y; Song Z; Bian J; Yi H; Ma Z
Front Immunol; 2023; 14():1095098. PubMed ID: 36845139
[TBL] [Abstract][Full Text] [Related]
20.
Liu L; Liang L; Liang H; Wang M; Lu B; Xue M; Deng J; Chen Y
Front Immunol; 2019; 10():1324. PubMed ID: 31249571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
